Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3025]

Advanced HCC: New systemic treatment options

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Surgical management of pancreatic cancer

Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia

Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Treating ovarian cancer patients with PARP inhibitors

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA

Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA

PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )

Benefits and challenges of using PARP inhibitors to treat metastatic breast...

Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA

Benefits and challenges of using PARP inhibitors to treat metastatic breast cancer ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )

Cancer immunotherapy for the advanced practice nurse

Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA

Cancer immunotherapy for the advanced practice nurse ( Krista Rubin - Massachusetts General Hospital Cancer Center, Boston, USA )

Benefits of cannabis legalisation to patients and oncology professionals

Eloise Theisen - Radicle Health, Walnut Creek, USA

Benefits of cannabis legalisation to patients and oncology professionals ( Eloise Theisen - Radicle Health, Walnut Creek, USA )

Pharmacology update from ONS 2019

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Pharmacology update from ONS 2019 ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Emerging uses of PARP inhibitors

Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA

Emerging uses of PARP inhibitors ( Teresa Knoop - Vanderbilt Ingram Cancer Center, Brentwood, USA )

Long-term safety of niraparib maintenance treatment in patients with recurrent...

Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )

More from ecancer